The inclusion of Dr. Naresh Trehan in a pharmaceutical marketing review panel faces backlash from patient groups over ...
Sun Pharma's Unolxcyt shows a significant objective response rate and durable cancer control for patients with advanced skin ...
Johnson & Johnson's experimental prostate cancer drug, JNJ-6143, has shown significant tumor shrinkage and reduced PSA levels ...
A groundbreaking study reveals that Amgen's Imdelltra, when combined with AstraZeneca's immunotherapy Imfinzi, significantly ...
Zymeworks has entered a global licensing agreement with Roche to develop and commercialize its experimental lung cancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results